Keyphrases
Ulcerative Colitis
100%
Inflammatory Bowel Disease
82%
Crohn's Disease
51%
Colorectal Cancer
36%
Confocal Laser Endomicroscopy
22%
Fecal Calprotectin
18%
Infliximab
18%
Remission
17%
Human Gut
16%
Gut-associated Lymphoid Tissue
16%
Tumor
16%
Tumor Necrosis Factor-α
16%
MicroRNA
15%
Disease Activity
14%
Ulcerative Colitis Patient
14%
Expression Level
14%
Inflammation
13%
MiR-92a
13%
Colitis
13%
Dysplasia
12%
Colitis-associated Dysplasia
12%
Colon Cancer
12%
Confidence Interval
11%
Small Bowel Cancer
11%
Metastatic Colorectal Cancer (mCRC)
11%
Cancer Inpatients
11%
Gene Copy number
11%
Tumor Heterogeneity
11%
E-health
11%
CDX2
11%
Intratumor
11%
Colonic Cancer
11%
Mucosal Healing
10%
Denmark
9%
Isolated Lymphoid Follicles
9%
Quality of Life
9%
MRNA Level
9%
Symptom Score
8%
Lymph Node Metastasis
8%
Geboes Score
8%
Randomized Controlled Trial
8%
MicroRNA-21 (miR-21)
8%
Collagenous Sprue
8%
Colonoscopy
8%
Endoscopy
7%
Early Metastatic
7%
Histological Score
7%
Transforming Growth Factor-β
7%
Intestinal Inflammation
7%
Epithelial Cells
7%
Medicine and Dentistry
Ulcerative Colitis
82%
Inflammatory Bowel Disease
58%
Neoplasm
40%
Colorectal Cancer
35%
Disease
24%
Colon Cancer
22%
Confocal Laser Scanning Microscopy
22%
Dysplasia
21%
Crohn's Disease
20%
Gut-Associated Lymphoid Tissue
16%
Patient with Inflammatory Bowel Disease
15%
Colonoscopy
14%
Biopsy
14%
Epithelial Cell
14%
Patient with Ulcerative Colitis
13%
Colitis
12%
Malignant Neoplasm
11%
Faecal Calprotectin
11%
Lymphatic Follicle
11%
Histopathology
11%
Intestine Cancer
11%
Ex Vivo
11%
e-Health
11%
Calgranulin
11%
Systematic Review
11%
Symptom
10%
Lymph Node Metastasis
10%
Randomized Controlled Trial
9%
Endoscopy
8%
Tumor Necrosis Factor
8%
Quality of Life
8%
Metastatic Carcinoma
8%
Pediatrics
7%
Collagenous Sprue
7%
Organoid
7%
Enteritis
7%
Injury
6%
Gastroenterology
6%
Microbiome
6%
Clinical Study
6%
Glucocorticoid
6%
Biological Marker
6%
Coeliac Disease
6%
Enteropathy
6%
Infliximab
6%
Intestine
6%
Patient with Crohn's Disease
6%
Cohort Analysis
6%
Merosin
6%
Image Analysis
6%
